The CCA, AIMp and the NPA* are taking measures to ensure greater protection for pharmacists and pharmacy staff facing increased levels of violence at work, they have told C+D.
Healthcare at Home, which delivers specialist medicines and provides nursing staff to administer them, has been told to improve after it failed to deliver medicines in time to thousands of patients, causing “a number of incidents where harm had occurred”.
The General Pharmaceutical Council (GPhC) will set pharmacy professionals’ registration fees for multiple years rather than reviewing them annually, it has announced after approving changes to its fees policy.
The GPhC has announced a pass rate of 81.6% for its second online registration assessment, which candidates sat across three sittings on July 27, 28 and 29.
An upcoming consultation on whether to make the COVID-19 vaccine mandatory for all health and social care staff will also consider extending the requirement to flu vaccinations, the Department of Health and Social Care (DH) has told C+D.
The NPA has called on the government’s competition watchdog to “look into” the hub-and-spoke dispensing model, to make sure it can exist without “undermining choice in the medicines supply chain and disadvantaging independent pharmacies”.
The Medicines and Healthcare products Regulatory Agency (MHRA) has asked pharmacies to “immediately” stop the supply of a specific batch of metformin oral solution, after a nitrosamine impurity was identified.
Pregabalin is no longer a “preferred option for the treatment of neuropathic pain” in new patients, following an increase in reported deaths involving the drug, community pharmacists and GPs in Northern Ireland (NI) have been told.
EMIS is considering implementing technology to support the hub-and-spoke dispensing model across community pharmacy, pending legislative changes, it has told C+D.
The Competition and Markets Authority (CMA) is to gather and analyse core information on more than 400 polymerase chain reaction (PCR) travel test providers, including some pharmacies, C+D understands.
The majority of respondents to C+D’s second annual racism in pharmacy survey have reported a lack of progress in tackling the issue, despite heightened awareness of racial inequality around the world.
The Medicines and Healthcare products Regulatory Agency (MHRA) has taken the "precautionary measure" of issuing a pharmacy/wholesaler level recall for a further 25 batches of irbesartan-containing medicines.
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.